2010Zhongguo xiandai yixue/Zhongguo xiandai yixue zazhiRequires access

Effect of benazepril combined with rosiglitazone on patients with diabetic nephropathy

Hui Chen

Open publisher page 0 citations

Abstract

ObjectiveTo observe the effect of benazepril combined with rosiglitazone on patients with diabetic nephropathy.MethodsA total of 84 patients with diabetic nephropathy treated in our hospital from January 2007 to December 2008 were randomly divided into treatment group and control group.Patients in both groups were given the same regimen including common treatment,insulin injection and benazepril.The patients in treatment group were added with rosiglitazone.ResultsTotal effective rate in the treatment group(88.1%) was higher than that in control group(66.7%) with significant difference(P 0.05).There were statistically significant differences in levels of Upr,SCr,BUN in two groups before and after treatment(both P 0.05).Post-treatment improvements in these parameters were more obvious in the treatment group than in the control group(P 0.05).ConclusionCombination of the two drugs can be synergistic against DN development,largely improve the therapeutic effect,thus is worth further clinical application.

About this research paper

What this paper is about

ObjectiveTo observe the effect of benazepril combined with rosiglitazone on patients with diabetic nephropathy.MethodsA total of 84 patients with diabetic nephropathy treated in our hospital from January 2007 to December 2008 were randomly divided into treatment group and control group.Patients in both groups were given the same regimen including common treatment,insulin injection and benazepril.The patients in treatment group were added with rosiglitazone.ResultsTotal effective rate in the treatment group(88.1%) was higher than that in control group(66.7%) with significant difference(P 0.05).There were statistically significant differences in levels of Upr,SCr,BUN in two groups before and after treatment(both P 0.05).Post-treatment improvements in these parameters were more obvious in the treatment group than in the control group(P 0.05).ConclusionCombination of the two drugs can be synergistic against DN development,largely improve the therapeutic effect,thus is worth further clinical application.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

ObjectiveTo observe the effect of benazepril combined with rosiglitazone on patients with diabetic nephropathy.MethodsA total of 84 patients with diabetic nephropathy treated in our hospital from January 2007 to December 2008 were randomly divided into treatment group and control group.Patients in both groups were given the same regimen including common treatment,insulin injection and benazepril.The patients in treatment group were added with rosiglitazone.ResultsTotal effective rate in the treatment group(88.1%) was higher than that in control group(66.7%) with significant difference(P 0.05).There were statistically significant differences in levels of Upr,SCr,BUN in two groups before and after treatment(both P 0.05).Post-treatment improvements in these parameters were more obvious in the treatment group than in the control group(P 0.05).ConclusionCombination of the two drugs can be synergistic against DN development,largely improve the therapeutic effect,thus is worth further clinical application.

Key concepts: Benazepril, Medicine, Rosiglitazone, Diabetic nephropathy, Urology, Regimen, Treatment and control groups, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of benazepril combined with rosiglitazone on patients with diabetic nephropathy — Research Paper | ScholarLens